Enzalutamide in Combination With Gemcitabine and Cisplatin in Bladder Cancer
Clinical trial NCT02300610 · COMPLETED
Trial details
- NCT number
- NCT02300610
- Sponsor
- H. Lee Moffitt Cancer Center and Research Institute
- Status
- COMPLETED
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2015-02-11
- Primary completion
- 2017-08-07
- Enrollment
- 10
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.